Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Joseph, B.
Right arrow Articles by Formstecher, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Joseph, B.
Right arrow Articles by Formstecher, P.
Related Collections
Right arrow Neoplasia
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Evidence for the Involvement of Both Retinoic Acid Receptor- and Retinoic X Receptor-Dependent Signaling Pathways in the Induction of Tissue Transglutaminase and Apoptosis in the Human Myeloma Cell Line RPMI 8226 

Bertrand Joseph, Olga Lefebvre, Claude Méreau-Richard, Pierre-Marie Danzé, Marie-Thérèse Belin-Plancot, and Pierre Formstecher

From the INSERM U459 «Signaux, Récepteurs et Différenciation Cellulaire», Faculté de Médecine, Lille cedex, France.

In this study, we show that both all-trans-retinoic acid (atRA) and 9-cis-retinoic acid (9-cis-RA) are potent inducers of tissue transglutaminase (TGase II), an enzyme involved in apoptosis, at the level of both enzyme activity and mRNA in the human myeloma cell line RPMI 8226. RPMI 8226 cells were shown to express mRNAs for all the retinoid receptors subtypes, ie, RARalpha , RARbeta , RARgamma , RXRalpha , RXRbeta , and RXRgamma . To identify which of these receptors are involved in regulating TGase II expression, several receptor-selective synthetic retinoids were used. Neither CD367, a very potent retinoid that selectively binds and activates receptors of the RAR family, nor CD2425, an RXR-selective agonist, induced TGase II when used alone. However, combination of CD367 and CD2425 resulted in nearly full induction of the enzyme. Moreover, when used in combination with atRA, CD367 partially inhibited the atRA-dependent induction of TGase II, whereas CD2425 enhanced it. The effects of Am 580, CD417, and CD437, three synthetic retinoids selective for the RARs subtypes RARalpha , RARbeta , and RARgamma , respectively, were also investigated. None of these compounds was able to induce TGase II when used alone; however, the combination of each of them with CD2425 resulted in strong induction of the enzyme activity, reaching 30% to 50% of the values obtained in the presence of retinoic acid and suggesting functional redundancy between the RAR subtypes. Finally, treatment with atRA or the combination of CD367 and CD2425, but not with CD367 or CD2425 alone, was also shown to trigger apoptosis in RPMI 8226 cells, with prominent accumulation of TGase II immunoreactivity in apoptotic cells. Taken together these data suggest that the induction of TGase II expression and apoptosis in the RPMI 8226 myeloma cell line required ligand-dependent activation of both the RAR and RXR receptors.

Blood, Vol. 91 No. 7 (April 1), 1998: pp. 2423-2432
© 1998 by The American Society of Hematology.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
S.-Y. Sun, N. Hail Jr, and R. Lotan
Apoptosis as a Novel Target for Cancer Chemoprevention
J Natl Cancer Inst, May 5, 2004; 96(9): 662 - 672.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Watashi, M. Hijikata, A. Tagawa, T. Doi, H. Marusawa, and K. Shimotohno
Modulation of Retinoid Signaling by a Cytoplasmic Viral Protein via Sequestration of Sp110b, a Potent Transcriptional Corepressor of Retinoic Acid Receptor, from the Nucleus
Mol. Cell. Biol., November 1, 2003; 23(21): 7498 - 7509.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. R. Krig, R. A. S. Chandraratna, M. M. J. Chang, R. Wu, and R. H. Rice
Gene-Specific TCDD Suppression of RAR{alpha}- and RXR-Mediated Induction of Tissue Transglutaminase
Toxicol. Sci., July 1, 2002; 68(1): 102 - 108.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Kinoshita, K. Koike, H. H. Mwamtemi, S. Ito, S. Ishida, Y. Nakazawa, Y. Kurokawa, K. Sakashita, T. Higuchi, K. Takeuchi, et al.
Retinoic acid is a negative regulator for the differentiation of cord blood-derived human mast cell progenitors
Blood, May 1, 2000; 95(9): 2821 - 2828.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Marchetti, N. Zamzami, B. Joseph, S. Schraen-Maschke, C. Mereau-Richard, P. Costantini, D. Metivier, S. A. Susin, G. Kroemer, and P. Formstecher
The Novel Retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphtalene Carboxylic Acid Can Trigger Apoptosis through a Mitochondrial Pathway Independent of the Nucleus
Cancer Res., December 1, 1999; 59(24): 6257 - 6266.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. J. Dilworth, C. Fromental-Ramain, E. Remboutsika, A. Benecke, and P. Chambon
Ligand-dependent activation of transcription in vitro by retinoic acid receptor alpha /retinoid X receptor alpha  heterodimers that mimics transactivation by retinoids in vivo
PNAS, March 2, 1999; 96(5): 1995 - 2000.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
B Mascrez, M Mark, A Dierich, N. Ghyselinck, P Kastner, and P Chambon
The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development
Development, January 12, 1998; 125(23): 4691 - 4707.
[Abstract] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 1998 by American Society of Hematology         Online ISSN: 1528-0020